Efficacy and safety analysis of different dose idarubicin plus cytarabine regimen as induction chemotherapy for young patients with de-novo acute myeloid leukemia

被引：0
|
作者：
张仪 [1 ]
机构：
[1] 1st Affil Hosp,Zhejiang Univ
来源：
China Medical Abstracts(Internal Medicine) | 2016年 / 33卷 / 04期
关键词：
AML; IA; were; Efficacy and safety analysis of different dose idarubicin plus cytarabine regimen as induction chemotherapy for young patients with de-novo acute myeloid leukemia; for; of; with;
D O I：
暂无
中图分类号：
R733.71 [急性白血病];
学科分类号：
100214 ;
摘要：
Objective To compare the efficacy,safety and longterm prognosis between different dose idarubicin(IDA)combined with cytarabine(IA)as induction chemotherapy in newly diagnosed young patients of acute myeloid leukemia(AML).Methods A total of 149 newly diagnosed young AML patients(APL excluded)between January 2009 to July 2014 was enrolled.According to the
引用
收藏
页码：231 / 231
页数：1
相关论文
共 50 条
  • [21] Prognosis of Patients With de novo Acute Myeloid Leukemia Resistant to Initial Induction Chemotherapy
    Wu, Sijing
    Yang, Shijia
    Zhu, Li
    Wang, Ying
    Zhang, Yicheng
    Zhou, Jianfeng
    Li, Dengju
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 351 (05): : 473 - 479
  • [22] Polysomy 8 in Egyptian patients with de-novo acute myeloid leukemia
    El Kerdany, Tahany Ali
    Kayed, Hesham Fayek
    Saad, Abeer Attia
    El-Gaafary, Shaymaa Salah El-Dine
    Moustafa, Nevine Nabil
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2012, 37 (04): : 213 - 220
  • [23] Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results
    Pigneux, Arnaud
    Perreau, Virginie
    Jourdan, Eric
    Vey, Norbert
    Dastugue, Nicole
    Huguet, Francoise
    Sotto, Jean-Jacques
    Salmi, L. Rachid
    Ifrah, Norbert
    Reiffers, Josy
    HAEMATOLOGICA, 2007, 92 (10) : 1327 - 1334
  • [24] Vancomycin-resistant enterococci in acute myeloid leukemia and myelodysplastic syndrome patients undergoing induction chemotherapy with idarubicin and cytarabine
    Heisel, Ronald W.
    Sutton, Robert R.
    Mascara, Gerard P.
    Winger, Daniel G.
    Weber, David R.
    Lim, Seah H.
    Oleksiuk, Louise-Marie
    LEUKEMIA & LYMPHOMA, 2017, 58 (11) : 2565 - 2572
  • [25] The impact of karyotype on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapy
    Mehta, J
    Powles, R
    Treleaven, J
    Swansbury, GJ
    Kulkarni, S
    Saso, R
    Min, T
    Singhal, S
    LEUKEMIA & LYMPHOMA, 1999, 34 (5-6) : 553 - 560
  • [26] The efficacy and safety of daunorubicin versus idarubicin combined with cytarabine for induction therapy in acute myeloid leukemia A meta-analysis of randomized clinical trials
    Wang, Hanyu
    Xiao, Xueting
    Xiao, Qirong
    Lu, Yanhong
    Wu, Yong
    MEDICINE, 2020, 99 (24) : E20094
  • [27] Addition of Lomustine to Idarubicin and Cytarabine Improves the Outcome of Elderly Patients With De Novo Acute Myeloid Leukemia: A Report From the GOELAMS
    Pigneux, Arnaud
    Harousseau, Jean-Luc
    Witz, Francis
    Sauvezie, Mathieu
    Bene, Marie-Christine
    Luquet, Isabelle
    Hunault-Berger, Mathilde
    Recher, Christian
    Lioure, Bruno
    Himberlin, Chantal
    Escoffre-Barbe, Martine
    Berthou, Christian
    Lissandre, Severine
    Fegueux, Nathalie
    Cahn, Jean-Yves
    Jourdan, Eric
    Dreyfus, Francois
    Reiffers, Josy
    Milpied, Noel
    Ifrah, Norbert
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18) : 3028 - 3034
  • [28] Efficacy and safety of consolidation therapy with intermediate and high dose cytarabine in acute myeloid leukemia patients
    Tangchitpianvit, Kittisak
    Rattarittamrong, Ekarat
    Chai-Adisaksopha, Chatree
    Piriyakhuntorn, Pokpong
    Rattanathammethee, Thanawat
    Hantrakool, Sasinee
    Tantiworawit, Adisak
    Norasetthada, Lalita
    HEMATOLOGY, 2021, 26 (01) : 355 - 364
  • [29] Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in FLT3-mutated acute myeloid leukemia
    Lee, Julia S.
    Wagner, Charlotte B.
    Prelewicz, Stacy
    Kurish, Heena P.
    Walchack, Robert
    Cenin, Danielle A.
    Patel, Seema
    Lo, Mimi
    Schlafer, Danielle
    Li, Belinda K. T.
    Harvey III, R. Donald
    Wasef, Bestis
    Ying, Jian
    Kovacsovics, Tibor
    REVISTA CHILENA DE LITERATURA, 2023, (108): : 3460 - 3463
  • [30] Attenuated dose of idarubicin for the elderly de novo acute myeloid leukemia with normal karyotype.
    Cheong, JW
    Kim, Y
    Park, SY
    Park, IH
    Kim, JS
    Min, YH
    BLOOD, 2005, 106 (11) : 231B - 231B
12345